Completed NA INTERVENTIONAL 1-arm NCT00821028

Local Paclitaxel Delivery for SFA Disease (IRRITAX)

Treatment of Superficial Femoral Artery Atherosclerotic Disease With Local Delivery of Paclitaxel Using an Irrigating Catheter: a Single-center Pilot Study

Sponsor: University of Oklahoma

Conditions Angioplasty Atherosclerosis Peripheral Arterial Disease

Interventions Paclitaxel

Updated 7 times since 2017 Last updated: Aug 14, 2017 Started: Jan 31, 2009 Primary completion: Dec 31, 2011 Completion: Apr 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Angioplasty and Atherosclerosis and is currently completed. University of Oklahoma leads this study, which shows 7 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Sep 2017 — Jun 2018 [monthly]

Completed NA

▶ Show 2 earlier versions

Feb 2017 — Sep 2017 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Oklahoma

Data source: University of Oklahoma

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oklahoma City, United States